These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Hourigan SK; Oliva-Hemker M; Hutfless S Dig Dis Sci; 2014 Sep; 59(9):2222-7. PubMed ID: 24788321 [TBL] [Abstract][Full Text] [Related]
32. Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection. Sokol H; Jegou S; McQuitty C; Straub M; Leducq V; Landman C; Kirchgesner J; Le Gall G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Richard ML; Beaugerie L Gut Microbes; 2018 Jan; 9(1):55-60. PubMed ID: 28786749 [TBL] [Abstract][Full Text] [Related]
33. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD. Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015 [TBL] [Abstract][Full Text] [Related]
34. [Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease]. Stallmach A; Reuken PA; Teich N Z Gastroenterol; 2018 Nov; 56(11):1369-1377. PubMed ID: 30419580 [TBL] [Abstract][Full Text] [Related]
35. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile. Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A; Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400 [TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors. Banaszkiewicz A; Kowalska-Duplaga K; Pytrus T; Pituch H; Radzikowski A Inflamm Bowel Dis; 2012 May; 18(5):844-8. PubMed ID: 21936029 [TBL] [Abstract][Full Text] [Related]
38. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis. Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568 [TBL] [Abstract][Full Text] [Related]
39. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study. Chen XL; Deng J; Chen X; Wan SS; Wang Y; Cao Q J Dig Dis; 2019 Sep; 20(9):460-466. PubMed ID: 31278840 [TBL] [Abstract][Full Text] [Related]
40. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease. Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]